MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4Jiaxin Lin, Min Zheng, Lan Zhang et al.|Oncotarget|2015Cited by 59
WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal TransitionYun Zhou, Min Zheng, Shuting Huang et al.|PLoS ONE|2016Cited by 56
Phase II trial of efficacy, safety and biomarker analysis of sintilimab plus anlotinib for patients with recurrent or advanced endometrial cancerWei Wei, Xiaohua Ban, Fan Yang et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 38
Anlotinib plus sintilimab in patients with recurrent advanced endometrial cancer: A prospective open-label, single-arm, phase II clinical trial.Wei Wei, Min Zheng, Xiaohua Ban et al.|Journal of Clinical Oncology|2021Cited by 2